79° F
May
21
Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Bevacizumab (drug)

Highlights

A collection of news and information related to Bevacizumab (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 35
» View baltimoresun.com items only
    Oct 24, 2012 |Story| Baltimore Sun

  1. 89 Md. facilities bought drugs from firm linked to meningitis outbreak

    The federal Food and Drug Administration identified 89 medical facilities in Maryland that bought drugs from the Massachusetts manufacturer being investigated for a national fungal meningitis outbreak.
    The federal Food and Drug Administration identified 89 medical facilities in Maryland that bought drugs from the Massachusetts manufacturer being investigated for a national fungal meningitis outbreak. The facilities are among more than 3,000 in numerous...

    Tags: Eyes and Vision, Charles Street, Harford County, Cambridge (Dorchester, Maryland), Medical Specialization

    2. Dec 30, 2011 |Story| Baltimore Sun

  2. Avastin shown to slow ovarian cancer

    A new international study shows that treating ovarian cancer with Avastin delays the disease progression and may improve survival. The drug, generically called bevacizumab, seemed to keep the disease from returning for two months. It was delayed five...

    Tags: Diseases and Illnesses, Health Treatments, Medical Specialization, Cancer, Drugs and Medicines

    3. May 10, 2013 |Story| Reuters

  3. RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    (Repeats to widen readership) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc...

    Tags: Merck & Company Incorporated, European Union, Pharmaceuticals, Conservation, Plavix (drug)

    4. May 10, 2013 |Story| Reuters

  4. XxANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown...

    Tags: Merck & Company Incorporated, European Union, Conservation, Pharmaceuticals, Plavix (drug)

    5. May 10, 2013 |Story| Reuters

  5. REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    (Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...

    Tags: Merck & Company Incorporated, European Union, Pharmaceuticals, Conservation, Plavix (drug)

    6. Apr 19, 2013 |Story| Los Angeles Times

  6. Strategies for cutting the cost of prescription drugs

    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it.
    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...

    Tags: Pharmaceuticals, Plavix (drug), Employment, Genentech Inc., Trials

    7. Apr 23, 2013 |Story| Los Angeles Times

  7. Cancer drug may double as fat-busting treatment for obesity

    Way back in 2002, Dr. Judah Folkman hit upon a tantalizing weight-loss strategy for obese mice. When given daily injections of a drug designed to fight cancer, their fat melted away. The higer the dose they got, the more fat they lost. Some of the obese mice shed so much weight that they wound up at &ldquo;near normal body weights,&rdquo; Folkman and his colleagues reported <a href="http://www.pnas.org/content/99/16/10730.full.pdf">in this article</a> in Proceedings of the National Academy of Sciences.
    Way back in 2002, Dr. Judah Folkman hit upon a tantalizing weight-loss strategy for obese mice. When given daily injections of a drug designed to fight cancer, their fat melted away. The higer the dose they got, the more fat they lost. Some of the obese...

    Tags: Obesity, Research, Weight, University of Mississippi, Medical Research

    8. Mar 29, 2013 |Story| Los Angeles Times

  8. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: Patient Protection and Affordable Care Act, Pharmaceuticals, Budget Control Act of 2011, Food and Drug Administration, Genentech Inc.

    9. Feb 19, 2013 |Story| Reuters

  9. Almost one-third of chemotherapy used 'off-label'

    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study.
    Reuters
    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study. Chemotherapies - drugs that kill rapidly dividing cells - are approved by the Food and Drug...

    Tags: Food and Drug Administration, Genentech Inc., Biotechnology, University of Chicago, Medical Specialization

    10. Dec 13, 2012 |Story| Reuters

  10. More pressure to justify cost of cancer drugs versus benefits

    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments.
    Reuters
    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could launch a high-priced drug with little push back. But now, there...

    Tags: Memorial Sloan-Kettering Cancer Center, PricewaterhouseCoopers, Pharmaceuticals, Patient Protection and Affordable Care Act, Food and Drug Administration

    11. Oct 16, 2012 |Story| Chicago Tribune

  11. Fake medicine poses growing threat to consumers

    Consumers shopping for medicine on the Internet often are getting convenience, a good price and the cloak of privacy, but they may not be getting the real thing.
    Consumers shopping for medicine on the Internet often are getting convenience, a good price and the cloak of privacy, but they may not be getting the real thing. A burgeoning multibillion-dollar industry of counterfeit drugs — ranging from AIDS...

    Tags: Pharmaceuticals, Computing and Information Technology Industry, Health and Personal Care, Sales, Drug Trafficking

    12. Oct 27, 2012 |Story| Los Angeles Times

  12. For the record

    Medical study results: In the Oct. 24 Section A, an article about medical studies said that follow-up studies of the drug Avastin showed that it did not help breast cancer patients live longer with their disease without getting worse. Those studies did...

    Tags: Football, Breast Cancer

 1  2 3 • Next >
Original site for Bevacizumab (drug) topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Bevacizumab (drug) Photos
A sign is displayed in front of the Genentech headquart...
(December 13, 2012)
A sign is displayed in front of the Genentech headquarters July 14, 2008 in South San Francisco, California. This company relied on the popularity of its cancer drug Avastin to boost profits.
, saying studies have failed to prove the drug's effect...
(July 1, 2011)
FDA panel rejects Avastin for breast cancer, but Medicare will still pay for it -- and Provenge
FDA's withdrawal will likely mean insurance companies w...
(June 29, 2011)
Avastin